Does the PITX2-region rs2200733 variant increase risk of atrial fibrillation and other atrial arrhythmias?

Genetic and clinical research establishes the rs2200733 variant, located near the PITX2 gene on chromosome 4q25, as a potent genetic marker for atrial fibrillation (AF) and a significant contributor to the broader landscape of atrial arrhythmias.

Clinical and effectiveness evidence

Large-scale genome-wide association studies (GWAS) and meta-analyses consistently identify the risk (T) allele of rs2200733 as a major driver of AF susceptibility.

• Effect Sizes: The risk allele is associated with odds ratios ranging from 1.48 to 2.03, with homozygous (TT) carriers experiencing the highest risk levels across diverse ancestries, including Caucasian and East Asian populations.
• Broader Arrhythmias: Beyond AF, the variant is significantly associated with atrial flutter. Carriers exhibit a higher propensity for developing AF following ablation for atrial flutter and face a 1.4 to 1.7-fold increased risk of recurring atrial tachyarrhythmias after pulmonary vein isolation or other ablation procedures.

Mechanistic explanations

The rs2200733 variant resides in an intergenic region approximately 150 kb upstream of the PITX2 gene. It functions as a regulatory element that modulates the expression of PITX2, a master transcription factor for cardiac development.

• Electrophysiological Remodeling: Reduced PITX2 expression leads to significant atrial electrical remodeling, characterized by increased heterogeneity in conduction velocity and the presence of complex fractionated signals.
• Developmental Dysregulation: PITX2 is essential for the formation of the pulmonary vein myocardial sleeve and for repressing the sinoatrial node (SAN) program on the left side of the heart. Disruption of this program leads to ectopic pacemaker activity and SAN dysfunction, creating a substrate highly susceptible to multiple forms of atrial tachyarrhythmia.
• Cellular Stress: PITX2 deficiency is linked to oxidative stress and mitochondrial dysfunction, which further contribute to slowed conduction and structural remodeling of the atria.

Bottom line

The PITX2-region rs2200733 variant is a well-validated genetic risk factor that substantially increases susceptibility to atrial fibrillation and broader atrial tachyarrhythmias by disrupting the developmental and electrophysiological regulation of the atria.